EMA asks for industry input on new guidance for anticancer development
This article was originally published in Scrip
Executive Summary
The European Medicines Agency (EMA) has launched a public consultation on its revised guideline on the evaluation of human anticancer medicines. The agency is accepting comments until 31 May.